Scotland · NHS Scotland MSAN
Dalteparin (Fragmin®) 10,000units/1mL solution for injection ampoule
MSAN(2023)2 · Level 3 · issued 16 Jan 2023
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| Valid until: discontinuation - stock to be exhausted by May 2023 | Discontinued | — |
| 1. Dalteparin (Fragmin®) 10,000units/1mL solution for injection ampoule has been discontinued. | Discontinued | — |
| remain available and will be able to support increased demand. | Available | — |
| (dalteparin (Fragmin®) 100,000units/4mL) as an alternative option to the discontinued product, | Discontinued | — |
| 10. Alternative dalteparin (Fragmin®) solution for injection products remain available (see Table 1 | Available | — |
| (dalteparin (Fragmin®) 100,000units/4mL) as an alternative option to the discontinued product, | Discontinued | — |
| discontinued product but will have a different administering process; or | Discontinued | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.